| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.17 | 0.4 |